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Abstract
Introduction: Breast cancer is the most frequent type of tumor and the second leading cause of
death in women. Metastases are present in nearly 60% of cases at the time of diagnosis with the
lymph nodes, skeleton, lungs, brain and liver as the most frequent sites of metastases. Gastrointestinal
involvement is rare, present in only 10% of all the cases. There is a very low risk of developing breast
cancer in men.
Case presentation: A 68-year-old man, with a past history of ductal breast cancer, presented with
duodenal obstruction. Medical treatment was attempted without success, so he underwent surgery
with subtotal gastrectomy and resection of the first portion of the duodenum. Histological
examination showed a duodenal metastasis originating from the previous carcinoma of the breast.
Five months after surgery, the patient is alive and well.
Conclusion: Gastrointestinal metastases should be considered in patients with a past history of
breast cancer. Surgical treatment should be performed in patients who are symptomatic and in good
general condition. To our knowledge this is the only case of a gastrointestinal metastasis from breast
carcinoma in a man.
Introduction
Breast cancer is the most frequent type of tumor and the
secondleadingcause of deathinwomen.[1].Metastasesare
present in nearly 60% of cases at the time of diagnosis. The
most frequent sites of metastases are the lymph nodes,
skeleton, lungs, brain and liver. Gastrointestinal involve-
ment is rare, and is detected in only 10% of all the cases [2].
There is a very low risk of developing breast cancer in men;
in the US there was an expectancy of nearly 2000 new cases
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metastasisusuallyderives fromlobularbreast cancerrather
than the much more common cell type of ductal breast
cancer. We report an extremely rare case of a 68-year-old
man who presented with intestinal obstruction due to a
solitary duodenal metastasis from an infiltrating ductal
carcinoma of the breast 40 months after breast surgery.
Case presentation
In December 2007 a 68-year-old man presented to our
institution as an emergency case with abdominal
pain, intractable vomiting and weight loss. There was
no family history of breast cancer or of other tumors;
neither was there any sign of exposure to epidemiologic
risk factors.
His relevant past history included an infiltrating ductal
carcinoma of the left breast for which he underwent a left
mastectomy with Halsted procedure in 2004. Prior to the
mastectomy, assessment had included a chest X-ray, bone
scan and an abdominal ultrasound, all of which were
negative. His carcinoembryonic antigen (CEA) and CA
15-3 results were in the normal range. A review of the
histology from his mastectomy specimen showed an
infiltrating ductal carcinoma of the left breast. The tumor
was 36 mm in maximum diameter infiltrating the
muscular tissue and ulcerating the skin; there was a
distance of 2 mm from the resection margins. Nine out of
22 lymph nodes isolated from the axillary cavity showed
evidence of metastases. Both estrogen and progesterone
receptors were positive. The expression of human epider-
mal growth factor receptor 2 (HER 2) protein was positive
(2+). However, a single focus of cribriform carcinoma was
found in the central lump.
The patient refused chemotherapy and was only treated
with hormonal therapy. Forty months after his first
operation, symptoms of upper intestinal obstruction
appeared.
A CT scan of his head, chest and abdomen did not show
any signs of metastases. A gastroscopy revealed a hemor-
rhagic duodenal ulcer with stenosis. This was treated
successfully with proton pump inhibitors (PPI); no
biopsies of the ulcer were taken in consideration of the
hemorrhagic risk, while biopsy of the gastric antrum
showed an helicobacter pylori (HP) negative gastritis. The
patient was discharged from the hospital with a scheduled
follow-up gastroscopy in one month.
The esophagogastroduodenoscopy (EGD). performed in
January showed the healed ulcer with duodenal subste-
nosis; the patient’s clinical condition improved and there
were no signs of intestinal obstruction. The benign nature
of the lesion was hypothesized and it was decided that
biopsy was not needed. Further, an endoscopic follow-up
was scheduled in three months.
In March 2008, the patient was again admitted to the
hospital with the same symptoms. A clinical examination
revealed a distended abdomen. The patient underwent a
gastroscopy that showed a duodenal stenosis with
hemorrhagic ulcer. A barium upper gastrointestinal (GI)
study confirmed the diagnoses. An endoscopic dilatation
was attempted without success.
A few days later the patient underwent exploratory
laparotomy, subtotal gastrectomy and resection of the
first portion of the duodenum. No signs of peritoneal
carcinomatosis were detected. On histopatological exam-
ination of the gastroduodenectomy, a poorly differen-
tiated carcinoma composed of nests or single strands of
atypic cells was identified in the duodenum (Figure 1).
Lymph nodes of greater and lesser curves did not show
evidence of metastasis. The proximal and distal resection
margins were tumor-free.
Immunohistochemical stains were positive for cytokeratin
(CK) 7 and estrogen receptors (ER) (Figure 2), whereas
staining with CK20 and CDX2 was negative (Figure 3). On
the basis of the histological and immunohistochemical
patterns of the tumor, a diagnosis of metastatic breast
carcinoma was made.
The patient’s recovery after the operation was uneventful.
The patient is alive and well and is responding well to the
systemic therapy. There have been no signs of recurrence
five months after surgery.
Figure 1. Metastases of breast carcinoma in the duodenum.
Upper left corner Brunner glands and bottom right neoplastic
cells arranged in a “string of beads” of Eosin Ematosillina
(100x).
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There is a very low risk of developing breast cancer in men;
in the US there was an expectancy of nearly 2000 new cases
of male breast cancer in 2008 [1]. Breast cancer is the
second leading cause of gastrointestinal metastasis in
women. In clinical practice, a diagnosis of gastrointestinal
metastasis from breast cancer is underestimated. Autopsy
studies showed that the frequency of gastric metastasis
varies between 7.4% and 18%, while a clinical study
of gastric involvement with breast cancer described only a
6% frequency during a five-year follow-up of 596 patients
[3-5].
In McLemore’s experience with 12,001 patients with
metastatic disease secondary to breast cancer, only 73
had gastrointestinal involvement. Twenty-three of these
patients had GI metastases, 32 had carcinomatosis and
18 had GI metastases and carcinomatosis [6].
Clinical diagnosis can be difficult due to nonspecific
symptoms like nausea, vomiting, dyspepsia, weight loss
and epigastric pain, all of which can be attributable to
chemotherapy, radiotherapy or liver metastasis. The mean
interval between a diagnosis of breast cancer and
presentation with a gastrointestinal metastasis can vary
from a few months to several years. Ayantunde et al.
describe a mean interval of 6.5 years ranging from
2.8 years to 32.8 years [7]. In Taal’s experience the mean
interval was four years ranging from 2 to 210 months [8].
In McLemore’s series the mean interval between the
primary diagnosis of breast cancer and GI metastatic
presentation was seven years. In 12 patients (16%) the GI
metastases was present at the time of their breast cancer
diagnosis [6].
Lobular carcinoma of the breast is less common,
representing only 10% to 15% of breast cancer. However,
it accounts for 80% of gastrointestinal metastases from
breast cancer. Taal et al. described 51 patients with gastric
metastases from breast cancer, 70% of which came from
infiltrating lobular tumor, while the primary histological
type was infiltrating ductal in only 15 cases [8,9].
McLemore states that, compared with the 12% frequency
of infiltrating lobular carcinoma in women with primary
breast cancer, the prevalence of infiltrating lobular
carcinoma in women with GI metastases was significantly
increased (54%) [6].
Gastrointestinal metastasis involves the upper gastroin-
testinal tract more frequently than the large bowel. An
endoscopic diagnosis can be difficult due to implantation
of the metastatic cells in the submucosa. A biopsy can be
negative for tumor cells in over 30% of cases. Imaging
techniques like CT scan or ultrasound-guided biopsy can
help in the diagnosis.
Immunohistochemistry is the most secure means of
making a diagnosis of breast cancer in these patients.
Metastases are usually positive for gross cystic disease fluid
protein 15 (GCDFP-15), cytokeratin 7, CEA, and estrogen
and progesterone receptors; however, they are negative for
cytokeratin 20 [10]. The presence of a gastrointestinal
metastasis from breast cancer is a sign of a systemic disease
which suggests poor survival; in Taal’s experience the
median survival in patients with a gastric metastasis is
10 months with a 2-year survival of 23% due to some
long-term survivors [8].
Late diagnosis of gastrointestinal metastasis is common,
and so is the presence of concurrent metastases at the time
of the diagnosis. In Taal’s series of gastric metastases, most
patients (94%) suffered from concurrent metastases,
mainly to the skeleton but also to the liver and lungs [8].
Due to its multicentric involvement, systemic therapy with
chemotherapy and/or hormonal therapy represent the best
adjuvant therapy options. Surgical treatment should be
taken into consideration for the treatment of intestinal
obstruction or in the rare case of a single metastasis
Figure 3. Neoplastic cells negative for cytokeratin 20 and
caudal type homeobox transcription factor 2. Neoplastic cells
negative for cytokeratin 20 in frame A and caudal type
homeobox transcription factor 2 in frame B (100x).
Figure 2. Neoplastic cells positive for cytokeratin 7 and
estrogen receptors. Upper left corner duodenum bottom
right neoplastic cells positive for cytokeratin 7 in frame A and
estrogen receptors in frame B (60x).
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underwent surgery, all of them for palliation only, to
alleviate severe symptoms of obstruction [8]. In
McLemore’s study of 23 patients with GI metastases,
12 underwent palliative surgery with a median survival
of 44 months compared to the median survival of nine
months of patients who were not treated surgically.
Surgery did not affect the survival of patients with
carcinomatosis [6]. All the data in the literature refers
to women. To our knowledge there is no report of a
gastrointestinal metastasis in a man.
Conclusions
In patients with a past history of breast cancer who present
with gastrointestinal symptoms, the presence of a metas-
tasis should be taken into consideration.
In a patient in good general condition, with the presence
of a single symptomatic metastasis, surgical treatment
should be considered strongly, especially when intestinal
obstruction symptoms are present. In this patient, surgical
treatment, without a histological diagnosis, was under-
taken to cure the symptoms.
In this patient, the metastasis appears to have been
completely resected. The patient’s recovery after his
operation was without complication. His obstructive
symptoms are no longer present.
To our knowledge this is the first report in the literature of
a duodenal metastasis from ductal breast carcinoma in a
man.
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